Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
Alimentary Pharmacology & Therapeutics|January 6, 2006
Peroxisome proliferator-activated receptor-alpha and -gamma mRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infectionA de Gottardi, V Pazienza, P Pugnale, et al.
Journal of Viral Hepatitis|January 15, 2010
Effect of antiviral therapy on circulating cytokeratin-18 fragments in patients with chronic hepatitis CC Sgier, B Müllhaupt, T Gerlach, et al.
Journal of Medical Virology|November 24, 1999
Hemochromatosis gene mutations in chronic hepatitis C patients with and without liver siderosisF Negro, K Samii, L Rubbia-Brandt, et al.
Swiss Medical Weekly|February 5, 2010
Impact of international consensus guidelines on antiviral therapy of chronic hepatitis C patients in SwitzerlandK Overbeck, J F Dufour, B Müllhaupt, et al.
Journal of Viral Hepatitis|January 1, 1995
The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferonF Negro, M L Abate, A Mondardini, et al.
Fertility and Sterility|August 1, 1985
Renin-like activity in ovarian follicular fluidL A Fernandez, B C Tarlatzis, P J Rzasa, et al.
Clinical and Diagnostic Virology|May 1, 1997
Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot studyD Flichman, P Colombatto, A Randone, et al.
Journal of Viral Hepatitis|December 13, 2012
IL28B polymorphisms predict response to therapy among chronic hepatitis C patients with HCV genotype 4N Antaki, S Bibert, K Kebbewar, et al.
Journal of Viral Hepatitis|January 23, 2015
HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patientsA Martini, G Fattovich, M Guido, et al.
Journal of Viral Hepatitis|July 6, 2012
Liver kidney microsomal type 1 antibodies reduce the CYP2D6 activity in patients with chronic hepatitis C virus infectionF Girardin, Y Daali, M Gex-Fabry, et al.
Pageof 20